Vildagliptin Attenuates Cardiac Hypertrophy and Improves Ventricular Efficiency Through FGF21 Expression in Pressure-overloaded Mouse Heart

被引:0
|
作者
Furukawa, Nozomi
Koitabashi, Norimichi
Sunaga, Hiroaki
Obokata, Masaru
Umbarawan, Yogi
Syamsunarno, Mas R.
Yamaguchi, Aiko
Matsui, Hiroki
Yokoyama, Tomoyuki
Kurabayashi, Masahiko
机构
关键词
Ventricular remodeling; Energy metabolism; Fibrosis; Diabetes Mellitus; Gene expression;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
12454
引用
收藏
页数:2
相关论文
共 46 条
  • [31] Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart
    Strand, Mari E.
    Herum, Kate M.
    Rana, Zaheer A.
    Skrbic, Biljana
    Askevold, Erik T.
    Dahl, Christen P.
    Vistnes, Maria
    Hasic, Almira
    Kvaloy, Heidi
    Sjaastad, Ivar
    Carlson, Cathrine R.
    Tonnessen, Theis
    Gullestad, Lars
    Christensen, Geir
    Lunde, Ida G.
    FEBS JOURNAL, 2013, 280 (10) : 2228 - 2247
  • [32] Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis
    Frunza, Olga
    Russo, Ilaria
    Saxena, Amit
    Shinde, Arti V.
    Humeres, Claudio
    Hanif, Waqas
    Rai, Vikrant
    Su, Ya
    Frangogiannis, Nikolaos G.
    AMERICAN JOURNAL OF PATHOLOGY, 2016, 186 (05): : 1114 - 1127
  • [33] Correlation of α-skeletal actin expression, ventricular fibrosis and heart function with the degree of pressure overload cardiac hypertrophy in rats
    Stilli, D
    Bocchi, L
    Berni, R
    Zaniboni, M
    Cacciani, F
    Chaponnier, C
    Musso, E
    Gabbiani, G
    Clément, S
    EXPERIMENTAL PHYSIOLOGY, 2006, 91 (03) : 571 - 580
  • [34] Reduction in Glucocorticoid Receptor Expression Attenuates Pressure Overload-induced Cardiac Hypertrophy and Promotes Heart Failure in Mice
    Wu, Rongxue
    Knapp, Maura
    Zheng, Mei
    Liao, James K.
    CIRCULATION RESEARCH, 2016, 119
  • [35] Suppression of Nrf2 attenuates adipogenesis and decreases FGF21 expression through PPAR gamma in 3T3-L1 cells
    Kim, Bo-Rahm
    Lee, Gha Young
    Yu, Hyeree
    Maeng, Hyo Jin
    Oh, Tae Jung
    Kim, Kyoung Min
    Moon, Jae Hoon
    Lim, Soo
    Jang, Hak Chul
    Choi, Sung Hee
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 497 (04) : 1149 - 1153
  • [37] Angiotensin receptor-neprilysin inhibitor attenuates cardiac hypertrophy and improves diastolic dysfunction in a mouse model of heart failure with preserved ejection fraction
    Zhang, Yue
    Yuan, Meng
    Suo, Ya
    Yang, Qian
    Shao, Shuai
    Li, Ying
    Wang, Yuanyuan
    Bao, Qiankun
    Liu, Tong
    Li, Guangping
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2022, 49 (08) : 848 - 857
  • [38] Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model
    Liao, YL
    Takashima, S
    Asano, Y
    Asakura, M
    Ogai, A
    Shintani, Y
    Minamino, T
    Asanuma, H
    Sanada, S
    Kim, J
    Ogita, H
    Tomoike, H
    Hori, M
    Kitakaze, M
    CIRCULATION RESEARCH, 2003, 93 (08) : 759 - 766
  • [39] Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) Through NF-κB/Brg1 and TGF-β1 Pathways Attenuates Cardiac Remodeling in Pressure-Overloaded Rat Hearts
    Qi, Han-Ping
    Wang, Ye
    Zhang, Qian-Hui
    Guo, Jing
    Li, Lei
    Cao, Yong-Gang
    Li, Shu-Zhi
    Li, Xiao-Lei
    Shi, Mu-Mu
    Xu, Wang
    Li, Bai-Yan
    Sun, Hong-Li
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (03) : 899 - 912
  • [40] Down-regulation of histone deacetylase 2 attenuates ventricular arrhythmias in a mouse model of cardiac hypertrophy through up-regulation of Kv channel-interacting protein 2 expression
    Liu, Wenjuan
    Liu, Jianping
    Wang, Gang
    Cheng, Wanwen
    Gong, Haochen
    Song, Yujuan
    Song, Ming
    Zhuge, Yixin
    Li, Ying
    Liu, Jie
    CARDIOVASCULAR RESEARCH, 2025,